AVY
77
2
NEM
61
-2
WEC
29
-5
THC
70
-2
ZBH
48
-2
BAC
48
10
PNR
72
10
HD
31
5
COP
51
-2
INTC
36
-5
C
46
2
ABT
50
3
UHS
62
-2
DTE
40
-2
GME
65
3
ABBV
40
-8
DNB
24
2
EW
38
-4
PSX
47
5
T
41
2
AVY
77
2
NEM
61
-2
WEC
29
-5
THC
70
-2
ZBH
48
-2
BAC
48
10
PNR
72
10
HD
31
5
COP
51
-2
INTC
36
-5
C
46
2
ABT
50
3
UHS
62
-2
DTE
40
-2
GME
65
3
ABBV
40
-8
DNB
24
2
EW
38
-4
PSX
47
5
T
41
2
Financhill
Back

Akero Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell
38

AKRO
Akero Therapeutics

Last Price:
19.72
Seasonality Move:
16.15%
Buy
56

LLY
Eli Lilly and

Last Price:
733.32
Seasonality Move:
3.18%
Sell
38
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $19.74. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Eli Lilly and (LLY) is a Buy

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $733.51. The Score for LLY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $19.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $733.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.34 Sell
Relative Strength Index (14 RSI): 33.69 Sell
Chaikin Money Flow: 413429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.72 - 24.08) Sell
Bollinger Bands (100): (20.12 - 26.06) Sell

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.76 Sell
Relative Strength Index (14 RSI): 42.89 Sell
Chaikin Money Flow: 1041343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (739.45 - 774.43) Sell
Bollinger Bands (100): (618.48 - 771.72) Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.45 Sell
20-day SMA: 21.84 Sell
50-day SMA: 24.58 Sell
200-day SMA: 28.82 Sell
8-day EMA: 20.42 Sell
20-day EMA: 21.77 Sell
50-day EMA: 23.08 Sell
200-day EMA: 27.44 Sell

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 736.33 Sell
20-day SMA: 752.43 Sell
50-day SMA: 761.34 Sell
200-day SMA: 622.61 Buy
8-day EMA: 736.95 Sell
20-day EMA: 747.27 Sell
50-day EMA: 741.12 Sell
200-day EMA: 632.53 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.58 per share, an increase next quarter of $0.02 per share, an increase this year of $6.18 per share, and an increase next year of $5.66 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):